[Use of anticoagulants in the combined treatment of nonspecific ulcerative colitis].

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Klinicheskaia meditsina

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 7120895
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Portal vein thrombosis in ulcerative colitis.

  1971cited by this paper
• Ulcerative proctitis: course and prognosis.

  1966cited by this paper

• Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.

  2015cites this paper
• Heparins in ulcerative colitis: proposed mechanisms of action and potential reasons for inconsistent clinical outcomes

  2015cites this paper
• Prevention of Venous Thromboembolism in Hospitalized Patients With Inflammatory Bowel Disease

  2013cites this paper
• Involvement of coagulation and hemostasis in inflammatory bowel diseases.

  2012cites this paper
• Unfractionated or low molecular weight heparin for induction of remission in ulcerative colitis: A cochrane inflammatory bowel disease and functional bowel disorders systematic review of randomized trials

  2011cites this paper
• Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.

  2010cites this paper
• Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.

  2008cites this paper
• Portal Vein Thrombi After Ileal Pouch-Anal Anastomosis: Its Incidence and Association with Pouchitis

  2007cites this paper
• Low‐molecular‐weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study

  2006cites this paper
• Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis

  2004cites this paper
• Medical management of severe ulcerative colitis.

  2004cites this paper
• Drug treatment of ulcerative colitis: unfractionated heparin, low molecular weight heparins and beyond

  2004cites this paper
• Randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis

  2003cites this paper
• [Complicated ulcerative colitis].

  2003cites this paper
• Protective effect of low molecular weight heparin on experimental colitis: role of neutrophil recruitment and TNF-alpha production.

  2002cites this paper
• [Coagulation system and inflammatory bowel disease: therapeutic and pathophysiologic implications].

  2002cites this paper
• Biological and novel therapies for inflammatory bowel disease in children.

  2002cites this paper
• Low Molecular Weight Heparin Treatment in Steroid Refractory Ulcerative Colitis: Clinical Outcome and Influence on Mucosal Capillary Thrombi

  2001cites this paper
• Heparin therapy for ulcerative colitis? Effects and mechanisms

  2001cites this paper
• Potential therapeutic applications and mechanisms of action of heparin in inflammatory bowel disease

  2000cites this paper
• Heparin, cell adhesion, and pathogenesis of inflammatory bowel disease.

  1999cites this paper
• Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease

  1999cites this paper
• Novel therapies for inflammatory bowel disease.

  1999cites this paper
• Treatment of corticosteroid‐resistant ulcerative colitis with heparin —a report of 16 cases

  1997cites this paper
• IBD: A Vascular Disorder? The Case for Heparin Therapy

  1997cites this paper
• Paradoxical response to heparin in 10 patients with ulcerative colitis.

  1995cites this paper
• 'Sticky' neutrophils, pathergic arthritis, and response to heparin in pyoderma gangrenosum complicating ulcerative colitis.

  1995cites this paper
• Hypercoagulability in inflammatory bowel disease.

  1994cites this paper